Global Ureterorenoscope Market Size By Type (Flexible Ureterorenoscopes, Rigid Ureterorenoscopes), By Application (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Ureterorenoscope Market was valued at USD 1.1 billion in 2023 and is projected to surpass USD 1.9 billion by 2031, growing at a CAGR of 7.0% during the forecast period from 2023 to 2031. This growth is primarily driven by the increasing prevalence of urolithiasis (kidney stones), rising demand for minimally invasive urological procedures, and advancements in endoscopic technologies. Ureterorenoscopy has become a preferred technique for the diagnosis and treatment of urinary tract disorders, especially stones located in the ureter and kidneys. The rapid adoption of flexible ureteroscopes, coupled with the growing geriatric population susceptible to urological issues, is further bolstering market expansion.

Drivers:

1. Rising Prevalence of Urolithiasis: A global rise in kidney stone cases, especially in developed and developing economies, is a major factor driving the demand for ureterorenoscopes. Lifestyle changes, dietary habits, and sedentary routines contribute to this growing medical condition.

2. Advancements in Ureteroscopic Technologies: Technological innovations such as digital flexible ureteroscopes, improved visualization systems, and single-use scopes have significantly enhanced the safety, efficiency, and cost-effectiveness of ureteroscopy procedures.

3. Preference for Minimally Invasive Procedures: Patients and physicians alike are favoring endourological solutions due to shorter hospital stays, faster recovery times, and lower risk of complications, leading to greater adoption of ureterorenoscopy.

Restraints:

1. High Equipment Cost: The initial investment for advanced digital or flexible ureteroscopes can be significant, especially for small- and medium-sized healthcare facilities, potentially limiting market penetration.

2. Risk of Procedure-Related Complications: Despite being minimally invasive, ureterorenoscopy carries the risk of ureteral injury, bleeding, and infection, which may deter some patients or delay treatment adoption in certain demographics.

Opportunity:

1. Expansion in Emerging Markets: Developing regions, particularly in Asia-Pacific and Latin America, offer lucrative growth opportunities due to rising healthcare infrastructure, increasing disposable income, and awareness campaigns promoting early urological diagnosis.

2. Rise of Single-Use Ureteroscopes: The growing inclination toward disposable ureteroscopes to prevent cross-contamination, reduce reprocessing costs, and improve efficiency is creating new opportunities for manufacturers.

Market by System Type Insights:

Based on system type, the Flexible Ureterorenoscope segment dominated the market in 2023 and is projected to maintain its lead during the forecast period. Their superior maneuverability, enhanced access to the renal pelvis, and better patient outcomes make them the preferred choice among urologists. Additionally, the rising popularity of digital and single-use variants is expected to drive rapid growth in this segment.

Market by End-use Insights:

The Hospitals segment accounted for the largest revenue share in 2023 due to the availability of advanced medical equipment, experienced urologists, and infrastructure to perform complex procedures. However, Ambulatory Surgical Centers (ASCs) are projected to witness the fastest growth owing to lower procedure costs, shorter waiting times, and increased focus on outpatient care.

Market by Regional Insights:

North America held the dominant position in the ureterorenoscope market in 2023, driven by advanced healthcare infrastructure, high adoption of technologically advanced endoscopy devices, and favorable reimbursement policies. Meanwhile, Asia-Pacific is anticipated to register the fastest CAGR during the forecast period, supported by growing awareness of kidney-related diseases, increasing healthcare investments, and a rapidly aging population in countries such as China and India.

Competitive Scenario:

Key players in the Global Ureterorenoscope Market include Olympus Corporation, KARL STORZ SE & Co. KG, Boston Scientific Corporation, Stryker Corporation, Richard Wolf GmbH, Coloplast Group, PENTAX Medical, and Dornier MedTech. These companies are actively involved in R&D, strategic collaborations, and product launches to maintain a competitive edge.

Recent Developments:

In 2024, Olympus launched a new line of single-use flexible ureteroscopes, improving safety and reducing reprocessing costs.

Boston Scientific introduced a digital platform integrating AI with ureterorenoscopic imaging systems in 2023, enhancing diagnostic accuracy.

Richard Wolf expanded its production facilities in Europe in 2025 to cater to growing global demand.

Scope of Work – Global Ureterorenoscope Market

Report Metric Details

Market Size (2023) USD 1.1 Billion

Projected Market Size (2031) USD 1.9 Billion

CAGR (2023–2031) 7.0%

Market Segments System Type (Flexible, Semi-Rigid, Rigid), End-Use (Hospitals, ASCs, Others)

Growth Drivers Rising prevalence of urolithiasis, advancements in endoscopic technologies

Opportunities Emerging markets, adoption of single-use ureteroscopes

Key Market Developments:

Olympus launched its disposable ureterorenoscope series in 2024 to improve infection control.

Stryker Corporation partnered with urology clinics in North America in 2023 to provide tailored surgical solutions.

PENTAX Medical invested in R&D for AI-powered imaging support tools in 2025 to assist real-time endoscopic procedures.

FAQs:

1) What is the current market size of the Global Ureterorenoscope Market?

The market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Ureterorenoscope Market?

The key growth driver is the rising prevalence of urolithiasis and increasing demand for minimally invasive urological procedures.

3) Which is the largest region during the forecast period in the Global Ureterorenoscope Market?

North America holds the largest market share due to advanced healthcare systems and high procedure volumes.

4) Which segment accounted for the largest market share in the Global Ureterorenoscope Market?

The Flexible Ureterorenoscope segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Ureterorenoscope Market?

Key players include Olympus Corporation, KARL STORZ, Boston Scientific, Stryker, and Richard Wolf GmbH.